<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="retraction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2026.13901</article-id>
<article-id pub-id-type="publisher-id">MMR-34-1-13901</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zou</surname><given-names>Peng</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xiaoxiao</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Gang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yangang</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>07</month><year>2026</year></pub-date>
<pub-date pub-type="epub"><day>05</day><month>05</month><year>2026</year></pub-date>
<volume>34</volume>
<issue>1</issue>
<elocation-id>191</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Zou et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Mol Med Rep 17: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="17" page="3212" id="RA1" xlink:href="10.3892/mmr.2017.8241" ext-link-type="doi">3212&#x2013;3217</related-article>, 2018; DOI: 10.3892/mmr.2017.8241</p>
<p>Following the publication of the above paper, it was drawn to the Editor&#x0027;s attention by a concerned reader that, in addition to the apparent duplication of control GAPDH western blots comparing Figs. 1A and 2C, the SIRT1 western blot data featured in Fig. 5A on p. 3215 had already been published previously in an article written entirely by different authors in different departments of the same research institute in the journal <italic>Mediators of Inflammation</italic>.</p>
<p>Owing to the fact that the contentious data in the above article had already been published prior to its submission to <italic>Molecular Medicine Reports</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
